UBE2S and ovarian carcinoma: The inhibition of PI3K/AKT/mTOR pathway by UBE2S could induce apoptosis and impede the cell cycle, thereby restraining the invasion and proliferation of ovarian cancer cells and correlating with poorer survival prognosis [56].